The Northern Ireland MHRA Authorised Route (NIMAR) provides a route for the lawful supply of POMs in compliance with UK and EU rules, where there is a risk that clinical need in NI for that product cannot be met. MHRA has updated their NIMAR guidance to reflect the Windsor Framework. They have confirmed the NIMAR process is still in place and likely will not be required once the Windsor Framework will come into effect. Under the Windsor framework, from January 2025 ‘PL GB’ packs will be allowed to be sold to Northern Ireland. For more information, click here.